Breckenridge Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?
BRECKENRIDGE PHARM has five approved drugs.
There are two tentative approvals on BRECKENRIDGE PHARM drugs.
Summary for Breckenridge Pharm
US Patents: | 0 |
Tradenames: | 5 |
Ingredients: | 5 |
NDAs: | 5 |
Patent Litigation for Breckenridge Pharm: | See patent lawsuits for Breckenridge Pharm |
PTAB Cases with Breckenridge Pharm as petitioner: | See PTAB cases with Breckenridge Pharm as petitioner |
Drugs and US Patents for Breckenridge Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge Pharm | TERBINAFINE HYDROCHLORIDE | terbinafine hydrochloride | TABLET;ORAL | 077714-001 | Jun 4, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Breckenridge Pharm | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 078069-003 | Jan 11, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Breckenridge Pharm | ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 078324-002 | Jun 9, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.